AAVantgarde Bio Srl
🇮🇹Italy
- Country
- 🇮🇹Italy
- Ownership
- Holding
- Established
- 2021-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.aavantgarde.com
Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- AAVantgarde Bio Srl
- Target Recruit Count
- 15
- Registration Number
- NCT06591793
- Locations
- 🇮🇹
University of Campania Luigi Vanvitelli, Naples, Italy
🇬🇧Moorfields Eye Hospital, London, United Kingdom
🇬🇧Retina Clinic London, London, United Kingdom
An Observational Study in Children and Adults With Stargardt Disease
Recruiting
- Conditions
- Stargardt Disease
- First Posted Date
- 2024-09-11
- Last Posted Date
- 2024-09-11
- Lead Sponsor
- AAVantgarde Bio Srl
- Target Recruit Count
- 80
- Registration Number
- NCT06591806
- Locations
- 🇺🇸
Retina Foundation of the Southwest, Dallas, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath